
Pravastatin
Pravastatin is a moderate-strength statin. At 40 mg it lowered LDL cholesterol by about 26 to 34 percent in large trials and reduced heart attacks and coronary deaths both in people with heart disease and in men with high cholesterol. It is a weaker LDL-lowerer than rosuvastatin or atorvastatin, but it has few food interactions: grapefruit does not affect it. The main points to watch are red yeast rice, a few prescription drugs, and spacing from bile acid binders.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with high LDL cholesterol or coronary heart disease who need moderate LDL lowering, and some children with familial high cholesterol, treated and monitored by a prescriber
Common dosing range
Set by your prescriber. The label gives a starting dose of 40 to 80 mg once daily for adults; severe kidney impairment starts at 10 mg with a 40 mg maximum
When to expect effects
LDL falls within weeks (the label suggests checking as early as 4 weeks); fewer heart events appeared over about 3 to 6 years in the large trials
Watch out for
Muscle injury (myopathy, rarely rhabdomyolysis) is uncommon (under 0.1 percent in trials) but more likely after age 65, with kidney impairment or untreated low thyroid, at higher doses, and with gemfibrozil, cyclosporine, clarithromycin or erythromycin. Statins, including pravastatin, lower blood CoQ10; whether CoQ10 supplements help muscle aches is unsettled, so ask your doctor before adding one
What is it
Pravastatin is a prescription cholesterol-lowering medicine in the statin class, sold in the US as generic pravastatin sodium tablets. It is used to lower LDL ("bad") cholesterol. In adults who already have coronary heart disease, it is approved to reduce the risk of coronary death, heart attack, artery procedures, and stroke or mini-stroke (TIA); in adults with high LDL who do not have coronary heart disease, to reduce the risk of heart attack, artery procedures and death from cardiovascular causes. It is also approved for children 8 and older with heterozygous familial hypercholesterolemia, the most common inherited form of high cholesterol. Pravastatin is one of the statins least affected by other substances: it does not depend on the CYP3A4 enzyme that grapefruit and many drugs block, so grapefruit juice did not change its blood levels in studies.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
coronary events and death in people with coronary heart disease Strong Evidence | About 24 percent fewer coronary deaths or heart attacks; 22 percent fewer deaths from any cause in LIPID | Adults with a past heart attack or unstable angina | Benefit built over 5 to 6 years of treatment |
first heart attack prevention in men with high cholesterol Good Evidence | 31 percent fewer first heart attacks or coronary deaths over 4.9 years | Middle-aged men with high LDL cholesterol and no heart disease | Over about 5 years |
heart events in adults aged 70 to 82 Good Evidence | About 15 percent fewer major events; no effect on stroke or cognition | Adults over 70 with vascular disease or risk factors | Over about 3 years |
survival compared with usual care in older adults with high blood pressure Good Evidence | No significant difference in deaths or coronary events | Not applicable | Assessed over 4.8 years |
coronary events and death in people with coronary heart disease
- Effect
- About 24 percent fewer coronary deaths or heart attacks; 22 percent fewer deaths from any cause in LIPID
- Best fit
- Adults with a past heart attack or unstable angina
- Time
- Benefit built over 5 to 6 years of treatment
first heart attack prevention in men with high cholesterol
- Effect
- 31 percent fewer first heart attacks or coronary deaths over 4.9 years
- Best fit
- Middle-aged men with high LDL cholesterol and no heart disease
- Time
- Over about 5 years
heart events in adults aged 70 to 82
- Effect
- About 15 percent fewer major events; no effect on stroke or cognition
- Best fit
- Adults over 70 with vascular disease or risk factors
- Time
- Over about 3 years
survival compared with usual care in older adults with high blood pressure
- Effect
- No significant difference in deaths or coronary events
- Best fit
- Not applicable
- Time
- Assessed over 4.8 years
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
coronary events and death in people with coronary heart disease
Disease adjunctIn LIPID, 9,014 people aged 31 to 75 with a past heart attack or hospital stay for unstable angina took pravastatin 40 mg or placebo for a mean 6.1 years. Coronary deaths fell from 8.3 to 6.4 percent (a 24 percent relative reduction) and deaths from any cause from 14.1 to 11.0 percent (22 percent), with fewer heart attacks (29 percent), strokes (19 percent) and artery procedures (20 percent). In CARE, 4,159 heart attack survivors with average cholesterol (mean LDL 139 mg/dL) took 40 mg or placebo for 5 years: coronary death or heart attack fell from 13.2 to 10.2 percent (24 percent), and strokes by 31 percent, but overall mortality did not differ significantly. In CARE, the benefit was larger in people with higher starting LDL.
Bottom line: Strong evidence that pravastatin lowers coronary deaths and heart attacks in people who already have heart disease.
first heart attack prevention in men with high cholesterol
Disease adjunctIn WOSCOPS, 6,595 Scottish men aged 45 to 64 with high cholesterol (mean 272 mg/dL) and no past heart attack took pravastatin 40 mg each evening or placebo for an average 4.9 years. LDL fell 26 percent. Nonfatal heart attack or coronary death occurred in 174 men on pravastatin versus 248 on placebo, a 31 percent relative reduction, and deaths from all cardiovascular causes fell 32 percent. The 22 percent drop in deaths from any cause just missed statistical significance (P = 0.051). Only men were studied.
Bottom line: One large trial shows pravastatin prevents first heart attacks in men with high cholesterol.
heart events in adults aged 70 to 82
Disease adjunctPROSPER gave pravastatin 40 mg or placebo to 5,804 men and women aged 70 to 82 with vascular disease or its risk factors for an average 3.2 years. LDL fell 34 percent, and coronary death, nonfatal heart attack or stroke fell from 473 to 408 events (hazard ratio 0.85). Coronary death and nonfatal heart attack fell by 19 percent, but stroke was not reduced (hazard ratio 1.03), and pravastatin had no significant effect on cognitive function or disability. New cancer diagnoses were more frequent on pravastatin in this trial, but when the authors added this result to a meta-analysis of all pravastatin and all statin trials, there was no overall increase.
Bottom line: In older adults, pravastatin lowered coronary events but not strokes over 3 years.
survival compared with usual care in older adults with high blood pressure
No benefit foundALLHAT-LLT randomized 10,355 adults aged 55 or older with treated high blood pressure and moderately high LDL to pravastatin 40 mg or usual care, without blinding, for a mean 4.8 years. All-cause mortality was the same (6-year rates 14.9 versus 15.3 percent; relative risk 0.99), and coronary events were not significantly lower (9.3 versus 10.4 percent). During the trial, 32 percent of usual-care participants with coronary heart disease and 29 percent without it started a cholesterol-lowering drug, so the LDL difference between groups was only about 17 percent; the authors say this small gap may explain the result.
Bottom line: In ALLHAT-LLT, pravastatin did not lower deaths compared with usual care, likely because the cholesterol difference was small.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose. Grapefruit is not a problem with pravastatin; red yeast rice, a few prescription drugs and bile acid binder timing are the main things to watch.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Myopathy and rhabdomyolysis (muscle breakdown that can damage the kidneys). Myopathy with creatine kinase above 10 times normal occurred in under 0.1 percent in trials. The label lists age 65 or older, uncontrolled hypothyroidism, kidney impairment, higher doses and certain other drugs (including other lipid-lowering therapies) as risk factors.
Immune-mediated necrotizing myopathy, a rare autoimmune muscle disease with weakness that persists after the statin is stopped
Liver enzyme rises (persistent increases above 3 times normal in about 1 percent on pravastatin or placebo) and rare liver failure; people who drink substantial amounts of alcohol or have liver disease may be at higher risk
Increases in HbA1c and fasting blood sugar
Who should avoid it
- People with acute liver failure or decompensated cirrhosis: contraindicated
- People with a past allergic reaction to pravastatin or the tablet ingredients: contraindicated
- People taking gemfibrozil: the label says to avoid the combination
- Pregnant people, unless their doctor has weighed the ongoing need (the label says to stop pravastatin when pregnancy is recognized or to weigh the individual need)
- People who are breastfeeding: the label says breastfeeding is not recommended during treatment
Pregnancy & breastfeeding
Pregnancy: the label says pravastatin may cause fetal harm based on how it works, and tells prescribers to stop it when pregnancy is recognized or to weigh the patient's ongoing needs; cholesterol treatment is generally not needed during pregnancy. Decades of observational data on statins have not shown a higher rate of major birth defects, but data on miscarriage are insufficient. Breastfeeding: one published lactation study found pravastatin in breast milk, and the label says breastfeeding is not recommended during treatment. If you are pregnant, planning a pregnancy or breastfeeding, talk to your doctor.
Interactions
The pravastatin label lists niacin among the drugs that may increase the risk of myopathy and rhabdomyolysis, reports cases with the combination and asks prescribers to weigh the benefit and watch for muscle symptoms. Unlike the Crestor and Zocor labels, it sets no niacin dose, and in its drug study niacin did not raise pravastatin levels, so the risk is the two muscle effects adding up. The rate has been measured only with another statin: in HPS2-THRIVE, adding extended-release niacin to simvastatin raised definite myopathy about 4-fold without reducing major vascular events. Do not add niacin for cholesterol without your prescriber, and show your pharmacist any high-strength B3 product.
These drugs raise pravastatin levels: in label studies, cyclosporine raised exposure by 282 percent and clarithromycin by 110 percent, increasing the risk of muscle breakdown. The label starts pravastatin at 10 mg and caps it at 20 mg with cyclosporine, and caps it at 40 mg with clarithromycin or erythromycin; it says other macrolides such as azithromycin may also raise levels. Make sure every prescriber knows you take pravastatin.
The label says to avoid gemfibrozil with pravastatin because of an increased risk of myopathy and rhabdomyolysis. Other fibrates (such as fenofibrate) can cause muscle injury on their own, and myopathy has been reported with colchicine plus pravastatin, so the label asks prescribers to weigh the benefit and watch for muscle symptoms.
Red yeast rice contains monacolin K, which is the same molecule as the statin lovastatin, so taking it with pravastatin stacks two statins. This is not an enzyme interaction; the concern is the added statin effect on muscles and liver, made harder to judge because testing of 12 products found 0.10 to 10.09 mg of monacolin K per capsule, and 4 had raised levels of citrinin, a kidney toxin in animals. The pravastatin label lists other lipid-lowering therapies among the risk factors for muscle injury. Review it with your doctor or pharmacist before combining.
The pravastatin label says people who drink substantial amounts of alcohol or have a history of liver disease may be at higher risk of liver injury. Light drinking is not addressed. Discuss your drinking with your doctor, and report yellow skin or eyes or dark urine.
Taken together, cholestyramine and colestipol lowered pravastatin exposure by about 51 and 47 percent. The label says to take pravastatin at least 1 hour before or at least 4 hours after the bile acid binder.
In 11 volunteers who drank 200 mL of double-strength grapefruit juice three times a day, the only change in pravastatin was a slightly later peak; levels were not raised. Label data agree (blood levels changed by under 4 percent). Grapefruit in ordinary amounts is not a problem with pravastatin, but check that your bottle says pravastatin, because simvastatin, lovastatin and atorvastatin are affected, and tell your pharmacist if other medicines you take depend on CYP3A4.
Soluble oat fiber may bind statins in the gut. The evidence comes from mice fed atorvastatin with oat bran, where the cholesterol-lowering effect of a low statin dose was halved; it has not been tested with pravastatin in people. Prescription bile acid binders, which also act in the gut, cut pravastatin levels by about half, which is why the label spaces them. Ask your pharmacist whether to space a large oat-fiber supplement apart from your dose.
Statins lower blood CoQ10 because they block the pathway that makes it; in a meta-analysis of placebo-controlled trials, pravastatin lowered plasma CoQ10 by about 0.43 micromol/L, similar to other statins. In a 500-person study from the LIPID trial, CoQ10 was lower on pravastatin than placebo (0.51 versus 0.60 micromol/L), but it did not predict heart attacks, strokes or heart deaths. Whether CoQ10 pills ease statin muscle aches is unsettled: one meta-analysis of 12 trials found less muscle pain, another of 7 trials found no benefit. This is not a harmful combination; if you have muscle symptoms, talk to your prescriber before adding anything.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ niacin
highNiacin adds to pravastatin's risk of muscle injury (myopathy), including rare rhabdomyolysis, a severe breakdown of muscle that can harm the kidneys. The pravastatin label lists niacin among the drugs that may increase this risk, reports cases with the combination and asks prescribers to weigh the benefit and watch for muscle symptoms. Its drug study found niacin did not raise pravastatin levels, so the risk comes from the two muscle effects adding up. Unlike the rosuvastatin and simvastatin labels, which name lipid-modifying doses of 1 gram a day or more, the pravastatin label sets no dose, and the size of the risk has been measured only with simvastatin, where adding niacin raised definite myopathy about 4-fold.
+ red yeast rice
moderateRed yeast rice contains monacolin K, a compound chemically identical to the statin lovastatin. Taking it alongside pravastatin means two HMG-CoA reductase inhibitors are active at the same time, so their cholesterol-lowering statin effect and their potential for muscle injury (muscle pain, and rarely rhabdomyolysis) add together. Because pravastatin is water-soluble and is not broken down by the CYP3A4 enzyme, this is not a metabolic (drug-processing) interaction; it is simply the additive effect of stacking two statin-type ingredients, made harder to gauge by red yeast rice's variable, unlabeled monacolin content.
+ coq10
lowPravastatin blocks HMG-CoA reductase, the enzyme at the start of the pathway that makes both cholesterol and coenzyme Q10 (CoQ10), so it lowers blood CoQ10. In a meta-analysis of placebo-controlled trials, pravastatin lowered plasma CoQ10 by about 0.43 micromol/L, similar to other statins, and in a 500-person study from the LIPID trial, CoQ10 was lower on pravastatin than placebo (0.51 versus 0.60 micromol/L) but did not predict heart attacks, strokes or heart deaths. Taking CoQ10 with pravastatin is not known to be harmful, and whether CoQ10 pills ease statin muscle aches is unsettled, because pooled trials disagree.
+ grapefruit
lowUnlike simvastatin, lovastatin, and atorvastatin, pravastatin is not significantly broken down by the gut enzyme CYP3A4 that grapefruit blocks. Controlled pharmacokinetic studies show grapefruit juice does not meaningfully change pravastatin levels, so grapefruit in normal dietary amounts is fine with this statin.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I eat grapefruit or drink grapefruit juice with pravastatin?⌄
Yes, in ordinary amounts. Pravastatin does not depend on the CYP3A4 enzyme that grapefruit blocks, and in a study of 11 volunteers drinking large amounts of double-strength grapefruit juice, pravastatin levels were not raised. Check that your bottle says pravastatin, since simvastatin, lovastatin and atorvastatin do interact with grapefruit, and tell your pharmacist if any other medicine you take is affected by it.
Can I take red yeast rice with pravastatin?⌄
Not without your prescriber's agreement. Red yeast rice contains monacolin K, the same compound as the prescription statin lovastatin, in amounts that varied 100-fold between products in one analysis. Taking it with pravastatin means taking two statins, which adds to the risk of muscle and liver problems.
Are pomegranate and bergamot safe with pravastatin?⌄
The concern with both is that they might block CYP3A4 like grapefruit, and that matters little for pravastatin, which grapefruit did not affect. Pomegranate juice did not change levels even of simvastatin, a statin that does depend on CYP3A4. Neither has been tested directly with pravastatin, and bergamot supplements can change your LDL results, so tell your prescriber or pharmacist if you use them.
Does pravastatin lower CoQ10, and should I take a supplement?⌄
Statins as a group lower CoQ10 in the blood; a meta-analysis of placebo-controlled trials found a similar fall with pravastatin as with other statins. Whether CoQ10 supplements help statin muscle aches is unclear, because meta-analyses disagree. If you have muscle symptoms, ask your doctor to look for causes and discuss the options; do not stop pravastatin on your own.
Why does the label tell me to space pravastatin from cholestyramine or colestipol?⌄
These cholesterol binders work in the gut and can hold on to pravastatin, cutting the amount absorbed by about half when taken together. The label says to take pravastatin at least 1 hour before or at least 4 hours after the binder. Your pharmacist can help you set a schedule.
What muscle symptoms should I report on pravastatin?⌄
Unexplained muscle pain, tenderness or weakness, especially with fever or feeling generally unwell, and dark or cola-colored urine. Serious muscle injury is rare with pravastatin, but it is more likely with gemfibrozil, cyclosporine or some antibiotics, after age 65, and with kidney or untreated thyroid problems. Contact your prescriber promptly.
References by claim
coronary events and death in people with coronary heart disease
first heart attack prevention in men with high cholesterol
Shepherd et al., 1995 · PubMed (1995) link
heart events in adults aged 70 to 82
Shepherd et al., 2002 · PubMed (2002) link
survival compared with usual care in older adults with high blood pressure
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial et al., 2002 · PubMed (2002) link
Safety
Pravastatin sodium tablets prescribing information · DailyMed (FDA label) link
Interaction: Red yeast rice
Gordon et al., 2010 · PubMed (2010) link
Interaction: Grapefruit and grapefruit juice
Lilja et al., 1999 · PubMed (1999) link
Interaction: Oat fiber and oat bran
Eussen et al., 2011 · PubMed (2011) link
Interaction: Coenzyme Q10 (CoQ10)
Track Pravastatin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
